MannKind | MNKD - 流动资产

金融业

USD

USD 792.18M

现金及等价物

USD 74.88M

USD 33.65M

USD 291.58M

USD 171.03M

USD 119.91M

USD -69.24M

USD 17.92M

407

EPS每股收益

USD 0.01

股本和储备

USD -51.02M

USD 78.31M

债务利息支出

USD 13.87M

USD 2.63M

USD 548.44M

USD 667.9M

USD -15.95M

USD 119.65M

USD -69.24M

普通股股本

USD 307.83M

303.7

USD -20.93M

USD 111.96M

销售和管理费用

USD 29.09M

USD 35.31M

贸易债权人

USD 9.03M

应收帐款人

USD 38.37M

	流动资产	更改		日
Adma Biologics	USD 466.51M		63.86M	2025-12
BioCryst Pharmaceuticals	USD 404.35M		48.66M	2025-12
Eli Lilly	USD 55.63B		6.44B	2025-12
Halozyme Therapeutics	USD 825.21M		503.54M	2025-12
Insmed	USD 1.79B		137.6M	2025-12
Karyopharm Therapeutics	USD 89.75M		8.12M	2025-09
MacroGenics	USD 219.94M		12.15M	2025-12
MannKind	USD 291.58M		67.26M	2025-12
Merck	USD 47.56B		10.49B	2025-09
Minerva Neurosciences	USD 83.1M		70.08M	2025-12
Novavax	USD 978.28M		3.69M	2025-12
Novo Nordisk	DKK 25.71B		148.69B	2025-06
Pfizer	USD 46.92B		3.22B	2025-09
Sanofi	EUR 30.95B		3.09B	2025-12
Xencor	USD 599.82M		81.38M	2025-12